Biocon Biologics gets US FDA nod for biosimilar version of e

Biocon Biologics said on Tuesday that the US Food and Drug Administration (US FDA) has approved the company's first-to-file application for Yesafili, a biosimilar drug for treating eye ailments.The company said the medicine is similar to the ...

Related Keywords

United States , Bengaluru , Karnataka , India , Shreehas Tambe , Biocon Biologics , Drug Administration ,